What does CHR. OLESEN NUTRITION BENELUX do?

CHR. OLESEN NUTRITION BENELUX is a wholesaler in Kontich. Public Limited, started on 4 November 2014, 1 establishment.

What is the address of CHR. OLESEN NUTRITION BENELUX?

The registered office of CHR. OLESEN NUTRITION BENELUX is located at Prins Boudewijnlaan 21-L, 2550 Kontich.

Is CHR. OLESEN NUTRITION BENELUX still active?

Yes. According to the CBE (30 October 2026) CHR. OLESEN NUTRITION BENELUX is active, legal situation “Normale toestand”, started on 4 November 2014.

Is CHR. OLESEN NUTRITION BENELUX registered on Peppol?

Yes, CHR. OLESEN NUTRITION BENELUX is registered on the Peppol network with ID 0208:0567646671.

What is the enterprise number of CHR. OLESEN NUTRITION BENELUX?

The enterprise number of CHR. OLESEN NUTRITION BENELUX is BE0567646671.

When was CHR. OLESEN NUTRITION BENELUX founded?

CHR. OLESEN NUTRITION BENELUX was founded on 4 November 2014.

Who are the directors of CHR. OLESEN NUTRITION BENELUX?

According to the 2025 annual accounts, the directors of CHR. OLESEN NUTRITION BENELUX are: Bart DE SCHUTTER, Mads OLESEN, Christoph SCHRADER, David VAN DER VELDEN.

Is CHR. OLESEN NUTRITION BENELUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 November 2014; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did CHR. OLESEN NUTRITION BENELUX make in 2025?

CHR. OLESEN NUTRITION BENELUX posted a profit after taxes of € 622,351 in financial year 2025.

What is the revenue of CHR. OLESEN NUTRITION BENELUX?

In its most recent annual accounts (2025), CHR. OLESEN NUTRITION BENELUX reported revenue of € 10,334,777.

CHR. OLESEN NUTRITION BENELUX (Public Limited) - Kontich

Dossier CHR. OLESEN NUTRITION BENELUX, printed on 30 October 2026 from databakkes.be/en/0567646671/chr-olesen-nutrition-benelux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CHR. OLESEN NUTRITION BENELUX from Kontich, company number BE0567646671, closed financial year 2025 with a result of € 622,351 after tax. For that financial year CHR. OLESEN NUTRITION BENELUX recorded revenue of € 10.3 million and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 658,607 to € 622,351. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Growing

€ 2.1 million

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 622,351

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 28,971

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 500,000 paid out

80 % of the profit went to the shareholders, mostly to CHR. OLESEN A/S (60 % of the shares). That is where the money ends up.

Debts at end 2025

Bank debt

€ 3.1 million

▲ 63% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 855,685

▼ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 33 days on average.

Taxes

€ 37,169

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 18,394,941 Revenue 2022: € 18,394,941 First fiscal year in the series	€ 16,540,445 Revenue 2023: € 16,540,445 ▼ 10% vs 2022 (€ 18,394,941) Unfavourable step	€ 10,087,009 Revenue 2024: € 10,087,009 ▼ 39% vs 2023 (€ 16,540,445) Unfavourable step	€ 10,334,777 Revenue 2025: € 10,334,777 ▲ 2% vs 2024 (€ 10,087,009) Favourable step	▲ 2%
Profit after taxes	€ 1,121,828 Profit after taxes 2022: € 1,121,828 First fiscal year in the series	€ 998,815 Profit after taxes 2023: € 998,815 ▼ 11% vs 2022 (€ 1,121,828) Unfavourable step	€ 658,607 Profit after taxes 2024: € 658,607 ▼ 34% vs 2023 (€ 998,815) Unfavourable step	€ 622,351 Profit after taxes 2025: € 622,351 ▼ 6% vs 2024 (€ 658,607) Unfavourable step	▼ 6%
Equity	€ 1,575,715 Equity 2022: € 1,575,715 First fiscal year in the series	€ 1,774,530 Equity 2023: € 1,774,530 ▲ 13% vs 2022 (€ 1,575,715) Favourable step	€ 1,933,137 Equity 2024: € 1,933,137 ▲ 9% vs 2023 (€ 1,774,530) Favourable step	€ 2,055,488 Equity 2025: € 2,055,488 ▲ 6% vs 2024 (€ 1,933,137) Favourable step	▲ 6%
Total debts	€ 8,713,778 Total debts 2022: € 8,713,778 First fiscal year in the series	€ 5,844,581 Total debts 2023: € 5,844,581 ▼ 33% vs 2022 (€ 8,713,778) Favourable step	€ 5,780,386 Total debts 2024: € 5,780,386 ▼ 1% vs 2023 (€ 5,844,581) Favourable step	€ 5,318,115 Total debts 2025: € 5,318,115 ▼ 8% vs 2024 (€ 5,780,386) Favourable step	▼ 8%
Cash	-	-	-	€ 28,971 Cash 2025: € 28,971 First fiscal year in the series
Retained profit	€ 1,514,215 Retained profit 2022: € 1,514,215 First fiscal year in the series	€ 1,713,030 Retained profit 2023: € 1,713,030 ▲ 13% vs 2022 (€ 1,514,215) Favourable step	€ 1,871,637 Retained profit 2024: € 1,871,637 ▲ 9% vs 2023 (€ 1,713,030) Favourable step	€ 1,993,988 Retained profit 2025: € 1,993,988 ▲ 7% vs 2024 (€ 1,871,637) Favourable step	▲ 7%
Dividend	€ 800,000 Dividend 2022: € 800,000 First fiscal year in the series	€ 800,000 Dividend 2023: € 800,000 Unchanged (€ 800,000) Unchanged	€ 500,000 Dividend 2024: € 500,000 ▼ 37% vs 2023 (€ 800,000) Unchanged	€ 500,000 Dividend 2025: € 500,000 Unchanged (€ 500,000) Unchanged
Bank debt	€ 326,775 Bank debt 2022: € 326,775 First fiscal year in the series	€ 576,343 Bank debt 2023: € 576,343 ▲ 76% vs 2022 (€ 326,775) Unfavourable step	€ 1,929,472 Bank debt 2024: € 1,929,472 ▲ 235% vs 2023 (€ 576,343) Unfavourable step	€ 3,141,915 Bank debt 2025: € 3,141,915 ▲ 63% vs 2024 (€ 1,929,472) Unfavourable step	▲ 63%
Balance sheet total	€ 10,289,493 Balance sheet total 2022: € 10,289,493 First fiscal year in the series	€ 7,619,111 Balance sheet total 2023: € 7,619,111 ▼ 26% vs 2022 (€ 10,289,493) Unchanged	€ 7,713,523 Balance sheet total 2024: € 7,713,523 ▲ 1% vs 2023 (€ 7,619,111) Unchanged	€ 7,373,603 Balance sheet total 2025: € 7,373,603 ▼ 4% vs 2024 (€ 7,713,523) Unchanged	▼ 4%

Key figures of CHR. OLESEN NUTRITION BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to CHR. OLESEN NUTRITION BENELUX?

What happened at CHR. OLESEN NUTRITION BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Bart DE SCHUTTER stepped down as director. NBB
2029 Mads OLESEN stepped down as director. NBB
2029 Christoph SCHRADER stepped down as director. NBB
2029 David VAN DER VELDEN stepped down as director. NBB
Apr 28, 2026 New annual accounts for financial year 2025: profit of € 622,351 (▼ 6% vs 2024). Source: NBB ↗
2023 Bart DE SCHUTTER became a director. NBB
2023 Mads OLESEN became a director. NBB
2023 Christoph SCHRADER became a director. NBB

In short

From € 1.1 million profit in 2022 to € 622,351 profit in 2025.

Paid € 1.2 million in corporate taxes since 2022.

Best year ever: 2022, with € 1.1 million profit.

Paid out € 2.6 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

CHR. OLESEN A/S 60%

VERTICE BV 30%

FUDIUM NV 10%

CHR. OLESEN NUTRITION BENELUX

The shares are held by CHR. OLESEN A/S (60%), VERTICE BV (30%) and FUDIUM NV (10%).

Directors

According to the 2025 annual accounts

Bart DE SCHUTTER

Director

Also active at: QUERINO, Vertice, FUDIUM, BRIQ

since 2023 · until 2029

Mads OLESEN

Managing director

since 2023 · until 2029

Christoph SCHRADER

Director

since 2023 · until 2029

David VAN DER VELDEN

Managing director

Also active at: Chr. Olesen, FUDIUM, ELADO

since 2023 · until 2029

Shareholders

CHR. OLESEN A/S

60%

VERTICE BV

30%

FUDIUM NV

10%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Prins Boudewijnlaan 21-L

2550 Kontich

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

FUDIUM same network

€ 27.5 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0567.646.671

VAT number

BE 0567.646.671

Registered office

Prins Boudewijnlaan 21-L, 2550 Kontich

Names & denominations

CHR. OLESEN NUTRITION BENELUX

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

4 November 2014

Peppol

Active · Active since 23 Jan 2026

Activities · NACE

Groothandel in andere voedingsmiddelen, neg

Handelsbemiddeling in de groothandel in andere specifieke goederen

Goederenvervoer over de weg

View on CBE Public ↗ Annual accounts (NBB) ↗

CHR. OLESEN NUTRITION BENELUX

Financials

What happened to CHR. OLESEN NUTRITION BENELUX?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions